The aim of the new addendum is introducing improved and more effective approaches to design development, clinical trials, monitoring of their progress, documentation and reporting, and standards for the maintenance of electronic documentation and mandatory documents.

What will we discuss in Webinar?​

  • Quality and Risk Management
  • Preliminary assessment of possible risks specific to the study
  • Risk-based monitoring
  • Introduction of new technological processes and tools, subject to the guarantee of the protection of the subject and reliability of the results of the study

For whom?​

For drug developers, pharmaceutical and biotech companies and other participants of the clinical trial market.

Host:​

Irina Nikitina, QA and Training Manager, IPHARMA

How to participate?​

To participate in the webinar you should register.

On October, 11th, you will receive an email invitation with a link to the broadcast.

Participation is free of charge.​

Can I ask the questions?​

You can ask preliminary questions which you would like to discuss in the registration application.

It is also possible to ask questions in Chat form during the broadcast on the YouTube channel, you will need to log in with your Google Account or create an account.

What if I miss the webinar?​

All webinars are recorded and you can watch it on YouTube IPHARMA channel.


Please, sign up or sign in to leave a comment.